Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-25-171
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $400,000
Opportunity facts
- Assistance listings
-
- 93.393 Cancer Cause and Prevention Research
- 93.394 Cancer Detection and Diagnosis Research
- 93.395 Cancer Treatment Research
- 93.396 Cancer Biology Research
- 93.399 Cancer Control
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Higher Education Inst. (Private)
- Tribal Governments (Federally Recognized)
- Higher Education Inst. (Public)
- 501(c)(3) Nonprofits
- Public or Indian Housing Auth.
- Independent School Districts
- Non-501(c)(3) Nonprofits
- Small Businesses
- State Governments
- Special District Governments
- City/Township Governments
- For Profit Organizations
- County Governments
- Tribal Organizations (Not Federally Recognized)
- Other
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Cancer Institute (NCI) is seeking collaborative, multidisciplinary projects that will develop and characterize state-of-the-art biomimetic tissue-engineered technologies for cancer research. The projects will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program, which aims to advance innovative, well-characterized in vitro and ex vivo systems for cancer research, expand their breadth to several cancer types, and promote the exploration of cancer phenomena with biomimetic tissue-engineered systems. Eligible applicant types include higher education institutions, nonprofits, small businesses, and government entities. The NOFO was posted on November 22, 2024, and applications are due by May 7, 2025.
Recent federal grant awards in related programs have ranged from approximately $200,000 to over $2 million in total costs, with typical project periods spanning 2-5 years. The research is expected to be conducted at the applicant organizations' facilities across the United States, with potential for some international collaboration components, particularly for clinical trials.
Synopsis
Through this Notice of Funding Opportunity (NOFO), the National cancer Institute (NCI) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this NOFO will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program. The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-171-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity